Frontline Ltd.
NYSE:FROOil & Gas Midstream
-$0.57 today
- Market cap
- $9.89B
- Beta
- 0.02
- P/E (TTM)
- 9.6
- EPS (TTM)
- $4.06
- Dividend yield
- 8.06%
Volume 2.99M
Average 3.21M
FRO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Frontline Ltd.NYSE: FRO
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How FRO compares with its peers on the latest reported figures
- FRO's LTM Jun 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for FRO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding FRO) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for FRO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 749.38M | 1.43B | 1.8B | 2.05B | 1.97B |
| Cost of Revenue | 722.15M | 945.88M | 1.03B | 1.34B | 1.32B |
| Gross Profit | 27.23M | 484.33M | 776.11M | 705.68M | 644.05M |
| Gross Margin | 3.6% | 33.9% | 43.1% | 34.4% | 32.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 26.42M | 47.37M | 53.53M | 36.09M | 51.37M |
| Operating Expenses | 18.76M | 38.71M | 29.45M | (76.04M) | 51.37M |
| Depreciation & Amortization | 160.16M | 165.17M | 230.94M | 339.03M | 328.46M |
| EBITDA | 211.34M | 739.83M | 1.07B | 1.14B | 946.8M |
| EBITDA Margin | 28.2% | 51.7% | 59.2% | 55.8% | 48.2% |
| Operating Income | 8.48M | 445.62M | 746.67M | 781.71M | 592.68M |
| Operating Margin | 1.1% | 31.2% | 41.4% | 38.1% | 30.2% |
| Interest Income | 121K | 1.46M | 16.5M | 16.79M | 15.84M |
| Interest Expense | 61.51M | 98.71M | 178.5M | 302.32M | 233.23M |
| Other Income / Expenses | (18.8M) | 30.33M | (90.05M) | (278.46M) | (207.58M) |
| Income Before Tax | (10.33M) | 475.95M | 656.62M | 503.25M | 385.1M |
| Pre-Tax Margin | -1.4% | 33.3% | 36.4% | 24.5% | 19.6% |
| Income Tax Expense | 4.63M | 412K | 205K | 7.67M | 6.02M |
| Net Income | (14.96M) | 475.54M | 656.41M | 495.58M | 379.08M |
| Net Margin | -2.0% | 33.2% | 36.4% | 24.2% | 19.3% |
| EPS (Basic) | (0.06) | 2.22 | 2.95 | 2.23 | 1.70 |
| EPS (Diluted) | (0.06) | 2.22 | 2.95 | 2.23 | 1.70 |
| Weighted Avg Shares | 198.97M | 214.01M | 222.62M | 222.62M | 222.62M |
| Weighted Avg Shares (Diluted) | 198.97M | 214.01M | 222.62M | 222.62M | 222.62M |
Frontline Ltd.
NYSE:FRO
Intrinsic Alpha fair value
Locked
Current Price
$44.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.